| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 119,441 | 119,345 | 133,802 | 144,526 | | Cost of Revenue | 79,774 | 77,785 | 91,613 | 102,689 | | | Gross Profit | 39,667 | 41,560 | 42,189 | 41,837 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 47,905 | 48,194 | 49,866 | 55,133 | | Non Recurring | (174) | 708 | 181 | 15,307 | | Others | 3,507 | 3,427 | 3,789 | 4,486 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (11,571) | (10,769) | (11,647) | (33,089) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2 | 3,775 | 216 | (10,664) | | Earnings Before Interest And Taxes | (11,569) | (6,994) | (11,431) | (43,753) | | Interest Expense | 1,350 | 1,235 | 743 |
-
| | Income Before Tax | (12,919) | (8,229) | (12,174) | (43,753) | | Income Tax Expense |
-
| 5 | (162) |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,919) | (8,234) | (12,012) | (43,753) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,919) | (8,234) | (12,012) | (43,753) | | Preferred Stock And Other Adjustments | (54,724) |
-
| 27,300 | (74) | | | Net Income Applicable To Common Shares | ($12,919) | ($8,234) | $15,288 | ($43,827) |
|
0.11% Nasdaq 
0.01%
Income Statement
